Skip to main content

Tema Medicina S.R.L.

AMP Adds Tema Medicina's ATTIVA Subdermal RF Platform

Image
AMP Adds Tema Medicina's ATTIVA Subdermal RF Platform

Cordova, Tenn. – September 16, 2026 -- Aesthetic Management Partners (AMP) has added ATTIVA®, an intelligent subdermal radiofrequency platform developed by Italy's Tema Medicina S.R.L., to its aesthetic technology portfolio, the company announced.

ATTIVA delivers controlled thermal energy beneath the skin to remodel tissue

The platform uses a fine, insulated cannula to deliver radiofrequency energy into subdermal tissue, producing immediate collagen contraction while supporting progressive collagen and elastin regeneration. It targets the face, neck, jawline, submental area and body, and is designed as a minimally invasive option with limited downtime for most patients.